← Back to headlines
ImmunityBio Gains on New Anktiva Indication in NCCN Guidelines
ImmunityBio's stock has seen gains following the inclusion of a new Anktiva indication in the National Comprehensive Cancer Network (NCCN) guidelines.
17 Mar, 12:07 — 17 Mar, 12:07
Sources
Showing 1 of 1 sources
